BAMCO Inc’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-414,122
| Closed | -$29.9M | – | 359 |
|
2019
Q4 | $29.9M | Sell |
414,122
-11,534
| -3% | -$833K | 0.11% | 142 |
|
2019
Q3 | $59.7M | Buy |
425,656
+692
| +0.2% | +$97.1K | 0.25% | 94 |
|
2019
Q2 | $77.8M | Sell |
424,964
-5,606
| -1% | -$1.03M | 0.31% | 75 |
|
2019
Q1 | $68.5M | Buy |
430,570
+89,261
| +26% | +$14.2M | 0.29% | 84 |
|
2018
Q4 | $32.7M | Buy |
341,309
+19,713
| +6% | +$1.89M | 0.17% | 128 |
|
2018
Q3 | $45.4M | Buy |
321,596
+52,053
| +19% | +$7.35M | 0.19% | 120 |
|
2018
Q2 | $42.2M | Buy |
269,543
+86,280
| +47% | +$13.5M | 0.18% | 122 |
|
2018
Q1 | $29.5M | Buy |
183,263
+95,140
| +108% | +$15.3M | 0.14% | 146 |
|
2017
Q4 | $14.5M | Sell |
88,123
-5,335
| -6% | -$879K | 0.07% | 190 |
|
2017
Q3 | $5.82M | Buy |
93,458
+11,434
| +14% | +$712K | 0.03% | 220 |
|
2017
Q2 | $6.53M | Buy |
82,024
+4,514
| +6% | +$359K | 0.03% | 214 |
|
2017
Q1 | $5.51M | Sell |
77,510
-10,810
| -12% | -$768K | 0.03% | 219 |
|
2016
Q4 | $4.51M | Buy |
88,320
+14,989
| +20% | +$765K | 0.03% | 214 |
|
2016
Q3 | $3.38M | Buy |
73,331
+26,455
| +56% | +$1.22M | 0.02% | 227 |
|
2016
Q2 | $1.41M | Buy |
46,876
+40,472
| +632% | +$1.22M | 0.01% | 254 |
|
2016
Q1 | $205K | Hold |
6,404
| – | – | ﹤0.01% | 283 |
|
2015
Q4 | $373K | Sell |
6,404
-7,096
| -53% | -$413K | ﹤0.01% | 292 |
|
2015
Q3 | $571K | Buy |
13,500
+6,000
| +80% | +$254K | ﹤0.01% | 325 |
|
2015
Q2 | $547K | Buy |
+7,500
| New | +$547K | ﹤0.01% | 341 |
|